Monday, March 16, 2026

Why September Sees the Most Food Poisoning Cases: Tips to Stay Safe

As autumn arrives, food poisoning cases rise. Ensure proper food storage, thorough cooking, and maintain hygiene to prevent illness.

Axis of Evil Returns: Kim Challenges US With Hwasong-20 ICBMs and Russian Flag In Mass Military Show

North Korea celebrated its Workers' Party's 80th anniversary with a military parade, showcasing the new Hwasong-20 ICBM and close ties with Russia.

How the New South-North Forest Cooperation Pact Aims for 2050 Carbon Neutrality

The Korea Arboreta and Gardens Institute signed an agreement to preserve forest ecosystems and combat climate change on the Korean Peninsula.

Health

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube to sponsor Coachella, showcasing beauty tech and cosmetics to enhance global brand awareness.

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube brand will sponsor Coachella, showcasing beauty tech and products to enhance global brand awareness.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

KIMES 2026: How South Korea’s Medical Device Industry is Poised for Global Expansion

KIMES 2026 showcases Korea's medical device sector, highlighting digital growth and global expansion opportunities for domestic companies.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

How This New Blood Test Using Nanotechnology Could Change Brain Disease Monitoring Forever

South Korean researchers developed a blood test to track brain disease progression, potentially replacing imaging scans for monitoring.

How the New MOU Between Financial and Medical Institutions Will Transform Care for the Underprivileged

A new support system links community finance with public healthcare to aid financially vulnerable populations in accessing medical assistance.

Unlocking the Future of Healthcare: How Dong-A ST and Dou are Revolutionizing AI Solutions in 2026

Dong-A ST partners with Dou for AI solutions to enhance digital healthcare and improve patient experiences in hospitals nationwide.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Top News

- Our Sponsors Ad -

Follow us